GRAIL, Inc. (GRAL)
Nasdaq · Common stock · Services-Medical Laboratories
As of Oct 21, 2:17 PM ET15 min delayedAbout 15 minutes behind the market. Every member plan is real time.
Follow GRAL in real time
Real-time quotes, Pro Charting, the scanner and the alert feed on GRAL and every other US listing.
Start 5 days freeTry Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
GRAL at a glance
Key statistics
$5.57B
Market capitalization
- Previous close
- $124.67
- Open
- $122.95
- Day range
- $122.95 – $134.42
- Volume
- 334.1K
- Average volume (30 sessions)
- 1.36M
- Shares outstanding
- 44.67M
- Earnings per share
- $(8.77)
- Price / book
- 2.2
- Price / sales
- 33.7
- Beta (1 year, vs SPY)
- 2.80
Where the price sits in its year
52-week range
74% of the range
- Below the 52-week high
- -19.3%
- Above the 52-week low
- +223.6%
Completed sessions through Oct 20, 2026
Technical snapshot
Above its 50-day and 200-day averages
- 20-day average
- $133.05-6.3%
- 50-day average
- $99.92+24.8%
- 200-day average
- $76.32+63.4%
Between the conventional 30 and 70 bands.
-11.2%
1 week
+54.4%
1 month
+71.5%
3 months
+45.7%
Year to date
+44.3%
1 year
Price change over each window, from completed sessions. Past performance does not indicate future results.
Every plan: MACD, ATR, the 20- and 50-day ranges, five-year and all-history extremes and the full indicator set, live on Pro Charting.The member platform, in real time
What members do with GRAL
GRAL on Pro Charting
Every intraday interval in real time, the drawing kit and the full set of technical studies on GRAL.
See the plans →
Every planScreen names like GRAL
The real-time scanner: price, volume, technical, fundamental and chart-pattern filters across the whole US market.
See the plans →
Analysis Tools OnlySet a price line on GRAL
Put GRAL on your watchlist, draw the levels you care about, and My Dashboard tracks where it trades against them.
See the plans →
Stock Alerts + ToolsOpen alerts on GRAL
See whether there is an open premium alert on GRAL, with its entry, stop and exit, each one reviewed by an analyst before it is sent.
See the plans →
From the public news wire
GRAL headlines
SEC Form 4, most recent first
Insider filings
SUMME GREGORY L
+237
Director · Grant or award
$32.10K · Oct 15, 2026
Ofman Joshua J.
−2.1K
Chief Executive Officer, Director · Open-market sale
$293.39K · Oct 15, 2026
Ofman Joshua J.
−7.1K
Chief Executive Officer, Director · Open-market sale
$964.95K · Oct 15, 2026
Ofman Joshua J.
−1.0K
Chief Executive Officer, Director · Open-market sale
$134.38K · Oct 15, 2026
MIZELL STEVEN
+148
Director · Grant or award
$20.05K · Oct 15, 2026
CHASE WILLIAM J
+153
Director · Grant or award
$20.73K · Oct 15, 2026
Ofman Joshua J.
−400
Chief Executive Officer, Director · Open-market sale
$53.25K · Oct 15, 2026
Ofman Joshua J.
−6.0K
Chief Executive Officer, Director · Open-market sale
$830.47K · Oct 15, 2026
About GRAIL, Inc.
GRAIL Inc is a healthcare company focused on developing technologies for early cancer detection. The company has developed a multi-cancer early detection blood test that has the ability to detect all types of cancer, across all stages. It operates in one reportable operating segment which provides multi-cancer early detection testing and service.
- Exchange
- Nasdaq
- Security
- Common stock
- Industry
- Services-Medical Laboratories
- Headquarters
- Menlo Park, CA
- Employees
- 910
- Listed since
- Jun 12, 2024
- Website
- grail.com
Pick the desk that fits how you trade
Analysis Tools Only for the real-time scanner, Pro Charting and the research desk. Stock Alerts + Tools for the human-reviewed alert feed. Premium Membership for both, at one price.
Try Premium Membership free for 5 days. Card required. After 5 days it is $149 per month or $1,099 per year until you cancel. First-time members only.
Other plans from $39 a month. Pay by card, Apple Pay, Google Pay, Link, Cash App Pay or Amazon Pay through Stripe.